Prior exposure to bacteria attenuates viral disease of the respiratory tract: A role for IL-17 and innate immune memory?

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 2, 2014, Pages 126-128

  Mills, Kingston H G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; PERTUSSIS VACCINE;

ADAPTIVE IMMUNITY; ALLERGIC ASTHMA; ASTHMA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; BACTERIUM; BORDETELLA PERTUSSIS; CD4+ T LYMPHOCYTE; EDITORIAL; EXPOSURE; HELMINTH; HUMAN; HYGIENE HYPOTHESIS; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; INCIDENCE; INFLUENZA; INNATE IMMUNE MEMORY; INNATE IMMUNITY; LUNG; LYMPHOID CELL; MACROPHAGE; MUCOSA; MYCOSIS; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PERTUSSIS; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION; T LYMPHOCYTE; TH17 CELL; UNITED STATES; VIRUS INFECTION;

ANIMALS; BRONCHIOLITIS, VIRAL; FEMALE; IMMUNITY, INNATE; INTERLEUKIN-17; PERTUSSIS VACCINE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 84892637770     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Finlay CM, Walsh KP, Mills K H G. Induction of regulatory cells by helminth parasites: Exploitation for the treatment of inflammatory diseases. Immunol Rev (In press)
2. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012;336:1268-1273.
3. Gollwitzer ES, Marsland BJ. Microbiota abnormalities in inflammatory airway diseases - potential for therapy. Pharmacol Ther 2014;141:32-39.
4. Brady MT, O'Neill SM, Dalton JP, Mills KH. Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis. Infect Immun 1999;67:5372-5378.
5. Cesario TC. Viruses associated with pneumonia in adults. Clin Infect Dis 2012;55:107-113.
6. Schnoeller C, Roux X, Sawant D, Raze D, Olszewska W, Locht C, Openshaw PJ. Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism. Am J Respir Crit Care Med 2014;189:194-202.
7. Mills KH. Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 2008;38:2636-2649.
8. Sutton CE, Mielke LA, Mills KH. IL-17-producing gd T cells and innate lymphoid cells. Eur J Immunol 2012;42:2221-2231.
9. Jones SA, Sutton CE, Cua D, Mills KH. Therapeutic potential of targeting IL-17. Nat Immunol 2012;13:1022-1025.
10. Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, Wehkamp J, Feagan BG, Yao MD, Karczewski M, et al.; Secukinumab in Crohn's Disease Study Group. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 2012;61:1693-1700.
11. Papp KA, Leonardi C, Menter A, Ortonne JP, Krueger JG, Kricorian G, Aras G, Li J, Russell CB, Thompson EH, et al. Brodalumab, an antiinterleukin-17- receptor antibody for psoriasis. N Engl J Med 2012;366:1181-1189.
12. Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, Lavelle EC, McLoughlin RM, Mills KH. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 2013;9:e1003264.
13. Mielcarek N, Debrie AS, Raze D, Bertout J, Rouanet C, Younes AB, Creusy C, Engle J, Goldman WE, Locht C. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2006;2:e65.
14. Netea MG. Training innate immunity: the changing concept of immunological memory in innate host defence. Eur J Clin Invest 2013;43:881-884.
15. Zurita E, Moreno G, Errea A, Ormazabal M, Rumbo M, Hozbor D. The stimulated innate resistance event in Bordetella pertussis infection is dependent on reactive oxygen species production. Infect Immun 2013;81:2371-2378.